Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models. [electronic resource]
Producer: 20161024Description: 20 p. digitalISSN:- 1756-8722
- Acetyltransferases -- metabolism
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Basic Helix-Loop-Helix Transcription Factors -- metabolism
- Blotting, Western
- Carcinoma, Hepatocellular -- drug therapy
- Cell Hypoxia
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Drug Synergism
- Epithelial-Mesenchymal Transition -- drug effects
- Humans
- Hypoglycemic Agents -- administration & dosage
- Liver Neoplasms -- drug therapy
- Male
- Metformin -- administration & dosage
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Sorafenib
- Transcription Factors -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.